Publications
- Influence of albuminemia on the pharmacokinetics of infliximab in patients with inflammatory bowel diseases2011 | First Faculty of Medicine
- Changes of immunological profiles in patients with chronic myeloid leukemia in the course of treatment2010 | First Faculty of Medicine
- Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's diseasePublication without faculty affiliation
- Outcomes of Treatment With Infliximab for Ulcerative Colitis and Predictors of Sustained Clinical ResponsePublication without faculty affiliation
- Outcomes of Treatment With Infliximab for Ulcerative Colitis and Predictors of Sustained Clinical Response.Publication without faculty affiliation
- PHOSPHATIDYLSERINE-DEPENDENT ANTI-PROTHROMBIN (APS/PT) ANTIBODIES AND ANTIPHOSPHOLIPID (APL) ANTIBODIES IN ANTI-TNF-ALPHA ANTIBODY-TREATED PATIENTS WITH INFLAMMATORY BOWEL DISEASES (IBD)Publication without faculty affiliation
- Predictors of sustained response to infliximab in patients with Crohn´s disease: a single cohort study +1Publication without faculty affiliation
- Relationship Between Serum Trough Infliximab Levels and Serum Albumin in Patients With Inflammatory Bowel DiseasesPublication without faculty affiliation
- Determination of serum infliximab levels and levels of antibodies against infliximab - when, why and how?Publication without faculty affiliation
- Formation of antiphospholipid antibodies and antibodies to infliximab in anti-TNF-alpha antibody treated patients with inflammatory bowel diseasesPublication without faculty affiliation
Loading network view...